drugset

drugset / Trial / NCT00746395

Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy

NCT00746395 ↗

Phase 4 Completed 45 enrolled University of South Alabama Sucampo Pharmaceuticals, Inc. · collab Takeda · collab

RandomizedParallel-groupDouble-blindDiagnostic

Summary

This investigation is designed to compare lubiprostone and placebo for cleansing and propulsion in preparation for capsule endoscopy.

Timeline

Start: 2008-04
Primary completion: 2008-09
Completion: 2008-09

Publications

Hooks SB 3rd, Rutland TJ, Di Palma JA. Lubiprostone neither decreases gastric and small-bowel transit time nor improves visualization of small bowel for capsule endoscopy: a double-blind, placebo-controlled study. Gastrointest Endosc. 2009 Nov;70(5):942-6. doi: 10.1016/j.gie.2009.04.045. Epub 2009 Jul 4.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Lubiprostone	Small molecule	24 ug	Oral

Indications